Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.35 USD | -0.74% | +5.11% | +46.98% |
Jun. 22 | MannKind Corporation Announces Positive 17-Week Results from the INHALE-3 Study | CI |
May. 29 | MannKind Agrees to Cross License Deal With Pulmatrix | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+46.98% | 1.47B | |
+19.44% | 124B | |
+20.01% | 114B | |
+21.11% | 25.83B | |
-23.72% | 19.42B | |
-18.17% | 16.2B | |
-19.87% | 15.31B | |
+55.81% | 14.32B | |
+8.76% | 14.31B | |
-48.79% | 14.19B |
- Stock Market
- Equities
- MNKD Stock
- News MannKind Corporation
- MannKind : Oppenheimer Adjusts MannKind PT to $3 From $2.50, Maintains Outperform Rating